INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted liver attack: new combo therapy tested for tough cancers
Disease control TerminatedThis early-stage study tested a new drug called SD-101, delivered directly into the liver's main artery, for people with advanced liver cancer. It aimed to see if combining this local treatment with standard immunotherapy drugs was safe and could help control the cancer. The tria…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: TriSalus Life Sciences, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New scan could help doctors better target liver cancer treatments
Knowledge-focused TerminatedThis study tested a special type of scan to see if it could accurately measure how well the liver is working in patients with liver cancer. The goal was to see if tracking liver function before, during, and after standard treatments like radiation or surgery could help doctors pl…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC